GlassScriptPhysician profile
Mark S St Marie
NPI 1629150792
$4,459.28
in general payments reported to CMS, 2019-2025
23 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,560 · 2020: $525 · 2021: $468 · 2022: $561 · 2023: $620 · 2024: $590 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,344.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,465.74 | 2019-2025 | Rinvoq, Skyrizi, Linzess |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $455.24 | 2019-2021 | |
| Intercept Pharmaceuticals, INC. | $355.74 | 2019-2024 | |
| Pfizer INC. | $311.42 | 2019-2021 | |
| Celgene Corporation | $271.74 | 2021-2023 | Zeposia |
| Takeda Pharmaceuticals U.S.A., INC. | $257.57 | 2019-2024 | Gattex |
| Phathom Pharmaceuticals, INC. | $248.36 | 2024 | Voquezna |
| E.R. Squibb & Sons, L.L.C. | $217.32 | 2023 | Zeposia |
| Nestle Healthcare Nutrition INC. | $180.94 | 2021-2023 | |
| Janssen Biotech, INC. | $146.43 | 2019 | |
| Ironwood Pharmaceuticals, INC | $119.90 | 2019-2020 | |
| Ucb, INC. | $118.44 | 2019-2020 | |
| Sandoz INC. | $61.00 | 2024 | Hyrimoz |
| Allergan, INC. | $47.57 | 2019-2020 | |
| Smith+Nephew, INC. | $37.63 | 2023 | Grafix Pl, Versajet, Oasis |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $29.22 | 2019 | |
| Concordia Pharmaceuticals INC. | $29.14 | 2019 | |
| Exact Sciences Corporation | $22.23 | 2024 | Cologuard Collection Kit |
| Shire North American Group INC | $21.15 | 2019 | |
| Redhill Biopharma INC. | $17.63 | 2020 | |
| Olympus America INC. | $17.00 | 2019 | |
| Merck Sharp & Dohme LLC | $14.52 | 2019 | |
| Gilead Sciences, INC. | $13.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark St Marie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.